INTRODUCTION
It is well known that patients with granulocytopenia are predisposed to bacterial infections. Despite the development of new antibiotics, treatment of infections in granulocytopenic patients is often ineffective (1, 2) .
Pseudomionas aeruginosa infections are particularly common in these patients (3) , occurring in up to 25% of the subjects at risk (4).
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Granulocyte transfusion therapy is a direct approach to reconstitution of the granulocyte-deficient host.
With the recent refinement of methods for obtaining granulocytes, it is now possible to collect sufficient cells to evaluate their use in treatment of infections. Several recent clinical studies suggest that granulocyte therapy is effective, but these have not been well-controlled trials (5) (6) (7) . Experimental studies of granulocyte transfusions in leukopenic dogs have shown that transfused cells can alter the course of induced bacteremias (8, 9) , but these studies do not indicate if granulocyte transfusions are effective therapy for an established tissue infection.
Because the complicated circumstances of the infections of granulocytopenic patients make controlled trials of granulocyte transfusion therapy in man difficult to perform, we have developed a model of Pseudomonas pneumonia, in leukopenic dogs and studied granulocyte transfusion in this experimental setting. In a randomized controlled trial, we have established that granulocyte transfusions are an effective therapy for this model infection.
METHODS
Dogs. The dogs infected were 6-12-mo-old beagles, weighing 7-12 kg. They were chosen because of previous experience with the effects of total body irradiation on these dogs (10) and because dogs of this size could be easily handled. The dogs used as leukocyte and platelet donors were English-American foxhounds, weighing [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] kg. These animals, entirely unrelated to beagles, were chosen as blood product donors because of their large size and docile temperament. Beagles were not used as blood donors because their small size precluded repeated phlebotomy or leukaphoresis. All sensitive to gentamicin at 3 ,ug/ml and carbenicillin at 50-100 Ag/ml but resistant to most other antibiotics. The bacteria for inoculation were grown overnight in trypticase soy broth at 37°C. The morning of their use they were washed and centrifuged 2-3 times in 0.85%o saline, and the washed pellet was resuspended to a concentration of 5 X 108 bacteria/ml as determined spectrophotometrically (OD at 620 nm) and confirmed by quantitative agar pour plating.
The dogs were lightly anesthetized with intravenous sodium thiamylal (Surital, Parke, Davis & Co.), and one main stem bronchus was intubated with a sterile cuffed endobronchial tube with a radiopaque tip (Metras bronchographic catheter, 19 F, Rusch, Inc., New York). Through this tube, a sterile radiopaque catheter (polyethylene tubing, 0.037 cm internal diameter, no. 6572, Becton Dickinson & Co., Rutherford, N. J.) was passed beyond the tip of the endobronchial tube as far distal in the lung as possible with gentle pressure. The exact position of the tube and catheter was immediately determined wxith anterior-posterior and lateral chest X rays.
After determining the tube and catheter placement, 1 ml of the bacterial suspension, containing 5 X 108 bacteria, was injected through the catheter, which was then flushed with 30 ml of air. The time for the intubation and inoculation was less than 15 min, and the duration of anesthesia less than 30 min.
Experimiental design. To establish the infection model, dogs were inoculated with bacteria 4, 5, 6, and 7 days after irradiation and without prior irradiation. As controls, dogs were sham infected 6 days after irradiation by instilling 1 ml of phosphate-buffered saline without bacteria. In this series of experiments, pairs of dogs were simultaneously irradiated, and both members of a pair were inoculated with bacteria on the same day. One member of each pair received gentamicin starting 24 h after infection as described below; the other member received no antibiotic therapy.
In a second series of experiments, the effects of granulocyte transfusions were studied in a controlled randomized trial. Pairs of dogs were simultaneously irradiated, infected at 6 days post-irradiation, and identically handled until 24 h after infection. At this time, the animals were assigned by random allocation to receive either gentamicin without leukocyte support or gentamicin plus daily transfusions of at ' was administered intramuscularly until death or hematologic recovery. This gentamicin dose gave mean serum levels of 9.6 pag/ml at 30 min and 5.8 ALg/ml 3 h after injection, levels comparable to those observed in previous studies of gentamicin kinetics in dogs (11) . Blood products. Platelets were obtained from fresh acidcitrate-dextrose (ACD) 3 anticoagulated type A negative blood from the foxhound donors. The blood was centrifuged at 1,500 g for 4 min at 20'C and the platelet rich plasma removed. The platelets were concentrated by centrifuging the plasma for 10 min at 1,000 g at 20'C and the excess plasma discarded. All dogs were given 50-100 ml of platelet concentrate daily to keep peripheral platelet counts above 25,000/mm. Moribund animals, however, often had lower counts despite transfusions in the last 24-36 h of life.
Leukocytes were obtained by continuous flow centrifugation as previously described (12) . Indwelling arteriovenous shunts were inserted and the dogs leukaphoresed to obtain 100 ml of leukocyte-rich ACD anticoagulated suspension containing at least 5 X 109 leukocytes (3 X 109 granulocytes) by using a cell separator (NCI-IBM cell separator, Endicott, N. Y.). The donors were used for 3-7 days of repeated leukaphoresis. Before transfusion, the leukocytes and the platelet preparations were irradiated with 2,500 rads of gamma radiation from a 'cesium source (Gammator M, Kewx-aunee Scientific Equipment Corp., Adrian, Mich.). The cells were irradiated to eliminate the possibility that they might cause graft versus host disease. Under these circumstances, although other types of white blood cells were given in the leukocyte transfusions, the granulocytes were regarded as the predominant functional cells transferred.
Clinical obscrvationis. Rectal temperatures of the dogs were measured each morning for several days before infection, at 4 h after infection and each morning thereafter. Anterior-posterior chest X rays were taken daily for the first 4 days after inoculation and at 2-3 day intervals thereafter. The animals were examined at least every 8 h to assess their general condition, to administer antibiotics, and to record deaths.
Blood cell coUnts. Total and differential leukocyte counts were measured before radiation and daily thereafter. Counts were also done 4 h after Psendomonzas inoculation and 1 h after each leukocyte transfusion. From these counts, the percent recovery of the transfused cells was calculated by multiplying the 1-h post-transfusion increments (posttransfusion count minus pretransfusion count) by the blood volume and dividing by the number of cells transfused. Leukocyte counts were not systematically studied at any other posttransfusion interval. Counts of less than 1,500-2,000 cells/mm3 were done by direct visual counting with a hemocytometer; higher counts were measured with an electronic particle counter (model Fn, Coulter Electronics, Inc., Hialeah, Fla.). Differential counts were made on air-dried \Wright's stained smears. Daily platelet counts were done by phase microscopy.
Abbrcziationis used in this paper: ACD, acid-citratedextrose; CML, chronic myelogenous leukemia. 1 The effect of 350 rads of total body irradiation granulocytopenic (Fig. 1) . To study the relationship and *the endobronchial inoculation of Pseudomomas on the of irradiation and the blood granulocyte count to sustotal blood leukocyte, neutrophil, and lymphocyte counts. The . . . counts shown are mean values+1 SEM for eight dogs.
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ceptiblity to Pseudomonas infection, 11 dogs were irradiated and inoculated with bacteria 4-7 days postCultures, limulus tests, autopsies. Blood cultures were ob-irradiation. Four unirradiated dogs were also inocutained before and 4 h after infection and daily thereafter. lated. Two dogs were sham inoculated at 6 days post-5 ml of blood were inoculated into 50 ml of brain-heart irradiation. 9 of these 17 dogs received gentamicin; infusion liquid media and the bacteria identified by standard the others received no antibiotics. In this small trial, methods. Simultaneous plasma samples were assayed for there was no apparent difference in the course of the endotoxin by the limulus test (13) . At autopsy, cultures ofi heart blood, tracheal fluid, and lung tissue were obtained. infections of the dogs given or not given gentamicin. From the autopsy cultures, the Pseudomonas isolated were There was also no apparent effect of gentamicin on the identified with type-specific rabbit antisera.' At autopsy, clearance of Pseudomonas from the lung, a finding contissue from all major organs also was obtained and hema-firmed in the controlled trial to be discussed below. toxylin atid eosin stained sections examined. The number of days the irradiated dogs survived after inoculation was inversely related to the interval between radiation and infection and directly related to the granulocyte counts at the time of infection ( Fig. 2 and Table I ). In four dogs infected 4-5 days postirradiation (mean blood granulocytes = 2,950/mm3), four dogs had fever (mean temperature increase 1.50C), and three had very modest increases in their blood granulocyte counts (mean increase = 350/mm3) at 4 h postinfection. Two had pulmonary infiltrates within 48 h. At the time of autopsy, the inoculated Pseudomonas immunotype was recovered from only one of these dogs. The seven dogs infected 6 and 7 days after irradiation showed a greater susceptibility to development of lethal Pseudoinonias infection (Fig. 2) . All had fever at 4 h after infection (mean temperature increase 1.20C), and the fever lasted until their deaths. Seven had decreases in the blood granulocyte counts with infection (Table  I) , and six had pulmonary infiltrates within 48 h. Five of these dogs had the inoculated Pseudonzonas immunotype isolated from the lungs at autopsy. The two dogs which were sham infected at 6 days post-irradiation did not develop fever for at least 2 days after the saline inoculation. They did not develop pulmonary infiltrates after the saline inoculation, and they survived 6 days longer than the dogs infected with Pseudonzonas at the same interval post-irradiation (Fig. 2) .
Autopsies showed that all of these irradiated dogs died with pneumonia. In the six dogs from which the inoculated Pseudomonas was recovered at autopsy, the area of most dense consolidation corresponded to the site of Pseudovmonas inoculation. In the dogs from which Pseuidomnonas was not isolated, there was a diffuse bronchopneumonia from which a variety of gram-negative organisms was isolated. Histologically, these leukopenic dogs had necrosis, large clumps of bacteria, and edema in the area of pneumonia with a sparse mononuclear inflanmnmatory response.
Preliminary to the study of the therapeutic effects of granulocyte transfusions, a dog infected at 6 days postirradiation was given 5 X 99 leukocytes for 3 days, sacrificed, and autopsied at 2 h after the last transfusion. Dense collections of granulocytes were found in the site where the Pseudonionas had bcen inoculated but were not found in the opposite lung.
On the basis of the information from the study of these 17 dogs, it was concluded that Pseudomzonas pneumonia could be established regularly in leukopenic but not in normal dogs. The infection seemed to be more easily established at progressively lower blood granulocyte counts. To study granulocyte transfusion therapy, infection at 6 days after radiation was chosen, since this was the earliest time when there was clearly a fall, instead of a rise, in the granulocyte counts at 4 h after infection. It appeared to be also a time when the dogs would probably survive for at least 2-3 days after infection, which would allow enough time to evaluate the effects of the treatment regimens.
Controlled trial of granulocyte transfusions. The results of eight pairs of dogs treated with gentamicin or gentamicin plus transfusions indicated that the granulocyte-transfused dogs survived longer (Fig. 3) 
DISCUSSION
The possibility of using granulocyte transfusions to treat infections in granulocyte-deficient subjects has been considered for many years (16, 17) . The chief problem was the lack of techniques for obtaining sufficient cells from the blood of normal individuals to substantially raise the blood granulocyte counts (18) . This problem led numerous investigators to study the use of patients with chronic myelogenous leukemia (CML) as leukocyte donors (19) (20) (21) . Clinical trials suggested that leukocytes could reduce fever and favorably influence the course of infections in leukopenic subjects. It was also shown that CML leukocytes localized at sites of infections (22) . The possibility that these transfusions might lead to transplantation of the leukemia (23) (25) . Only an average of 7.2% of these transfused cells were present in the circulation at 1 h after transfusion. Thus the number of cells given may have been only marginally adequate to permit the dogs to survive the prolonged period of leukopenia. Second, since unmatched donors and recipients were used, it is also possible that the recipients became alloinmmunized to the donor leukocytes and that the transfusions given late in the course of therapy were less effective than those given shortly after infection. Finally, since gentamicin was the only antibiotic administered, the infections from which the dogs died may have been caused by bacteria resistant to gentamicin. Unfortunately, antibiotic sensitivities for the bacterial isolates were not done.
These studies showed that granulocyte transfusions prevented or delayed the development of a positive limulus test, probably by delaying the development of endotoxemia. Granulocy'tes (26) and buffy coat cells (27) are known to concentrate endotoxin and degrade it (28) . They appear to be more effective for detoxifying endotoxin than macrophages (29) . The effects of the granulocyte transfusions on the limulus tests could be attributable either to a local effect of the granulocytes on tissue bacteria which prevents endotoxin from reaching the blood or the cells could serve to concentrate and degrade the blood endotoxin. In either case, this effect of granulocytes in preventing endotoxemia may be a critical reason for the prolonged survival of the transfused animals.
In this trial, therapy of Pseudomonas infection with gentamicin and gentamicin plus granulocytes was compared by using a Pseudomonas organism which was sensitive to gentamicin at antibiotic concentrations which are readily attainable in serum. Gentamicin alone was clearly an ineffective treatment, as indicated by the recovery at autopsy of the inoculated Pseudomonas from seven of eight dogs given this therapy. It has been suggested that antibiotics acting against bacterial cell walls, e.g. carbinicillin or ampicillin, are more effective than the antibiotics which inhibit protein synthesis, e.g. the aminoglycosides, for treatment bacterial infections in granulocytopenic subjects (1, 30) . From this suggestion, it follows that granulocyte transfusion therapy should be compared with other antibiotic regimens. Furthermore, other antibiotics should be tried in concert with granulocyte therapy in order to evaluate more precisely how effective granulocyte therapy may be. Studies to compare such treatment regimens in this animal model are now in progress.
This model of Pseudomonas pneumonia in leukopenic dogs was developed in order to study the therapy of this infection in a controlled fashion. It is hoped that this clear demonstration of an effective role of granulocyte transfusion therapy in an animal model will prompt further clinical studies to define the specific circumstances in which granulocyte transfusions are of benefit in man.
